Data & Analytics Overview of TC-5619 Clinical Development

Year: 2015 TC-5619 Cliʜical Develʝpment www.clinInsight.com Overview Page 2 www.clinInsight.com SEC FilliŶgs Status Amount Amount Targacept entered into collaborative…

Documents Cognitive Disorders Kimberly Gregg MS, APRN,BC N483.

Slide 1 Cognitive Disorders Kimberly Gregg MS, APRN,BC N483 Slide 2 Objectives Define cognitive disorders. Discuss differences between reversible and irreversible cognitive…

Documents PowerPoint Cognitive Disorders

Cognitive Disorders Kimberly Gregg MS, APRN,BC N483 Objectives Define cognitive disorders. Discuss differences between reversible and irreversible cognitive disorders. Discuss…